Posted by Michael Wonder on 07 Aug 2017
Platform for post-authorisation studies registered as EU trade mark
7 August 2017 - ‘EU PAS Register’ includes more than 1,100 observational post-authorisation studies.
The European Union Intellectual Property Office (EUIPO) has approved the registration of ‘EU PAS Register’ as a European Union trade mark (EUTM). A EUTM grants exclusive rights in all current and future Member States of the European Union, and can be renewed every 10 years.
Launched in November 2010, the EU PAS Register is a unique source of information on the safety and effectiveness of authorised medicines. It is an openly accessible platform with information on observational post-authorisation research in medicines already marketed in Europe and includes study protocols, study results, related publications and other relevant information.
